Table 6.

Relative rates (95% CI) associated with the calendar year and risk at start of statin treatment period, in Poisson models modelling CVD incidence

	Female		Male
Model	Calendar year	Risk at start of treatment	Calendar year	Risk at start of treatment
Development cohort	0.96 (0.96–0.96)	NA	0.97 (0.97–0.97)	NA
Statin users cohort	0.94 (0.93–0.94)	NA	0.94 (0.94–0.94)	NA
Statin users cohort (also adjusting for 10-year risk at inception into cohort)	0.94 (0.94–0.94)	1.02 (1.02–1.03)	0.94 (0.94–0.94)	1.02 (1.02–1.02)